These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17361214)

  • 1. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
    Breckpot K; Aerts JL; Thielemans K
    Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
    Dullaers M; Thielemans K
    J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
    Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
    Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.
    Dullaers M; Breckpot K; Van Meirvenne S; Bonehill A; Tuyaerts S; Michiels A; Straetman L; Heirman C; De Greef C; Van Der Bruggen P; Thielemans K
    Mol Ther; 2004 Oct; 10(4):768-79. PubMed ID: 15451461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shuttle of lentiviral vectors via transplanted cells in vivo.
    Blömer U; Gruh I; Witschel H; Haverich A; Martin U
    Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.
    Chinnasamy N; Treisman JS; Oaks MK; Hanson JP; Chinnasamy D
    Gene Ther; 2005 Feb; 12(3):259-71. PubMed ID: 15668698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB; Anderson B; Weissman D
    Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vectors for immunization: an inflammatory field.
    Pincha M; Sundarasetty BS; Stripecke R
    Expert Rev Vaccines; 2010 Mar; 9(3):309-21. PubMed ID: 20218859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors for anti-tumor immunotherapy.
    Breckpot K; Emeagi PU; Thielemans K
    Curr Gene Ther; 2008 Dec; 8(6):438-48. PubMed ID: 19075627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
    Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
    Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.
    Wang H; Zhang L; Kung SK
    Immunotherapy; 2010 Sep; 2(5):685-95. PubMed ID: 20874652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-primate lentiviral vectors.
    Poeschla EM
    Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
    Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
    Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function.
    Teschemacher AG; Wang S; Lonergan T; Duale H; Waki H; Paton JF; Kasparov S
    Exp Physiol; 2005 Jan; 90(1):61-9. PubMed ID: 15542618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.
    Vigna E; Naldini L
    J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
    Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
    Mossoba ME; Medin JA
    Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.